Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

ICYMI: New Report on Benefits of Cancer Medicines That Emerge After FDA Approval

By Emma Van Hook  |    July 1, 2015
In case you missed it, Boston Healthcare Associates recently published a report examining how additional benefits of cancer medicines emerge over time through ongoing research after initial...   Read More

ASCO’s Framework: Value at the Crossroads

By Randy Burkholder  |    June 23, 2015
Yesterday the American Society of Clinical Oncology (ASCO) released its long-awaited draft conceptual framework to assess the value of cancer treatment options. PhRMA has long supported the...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates